Combined treatment with rapamycin and brain penetrant MEK inhibitor significantly reduces brain metastasis by prohibiting perivascular invasion of tumor cells and tumor angiogenesis in triple-negative breast cancer models (27). The gene discussed is MAP2K7; the disease is triple-negative breast carcinoma.